ESTIMATED
04/30/2024
04/30/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $0.69 | $0.69 | $0.69 |
Q2 2024 | 2 | $0.62 | $0.68 | $0.65 |
Q3 2024 | 0 | $0.57 | $0.57 | $0.57 |
Q4 2024 | 0 | $0.70 | $0.70 | $0.70 |
Q1 2025 | 1 | $0.84 | $0.84 | $0.84 |
Q2 2025 | 1 | $0.78 | $0.78 | $0.78 |
Q3 2025 | 1 | $0.71 | $0.71 | $0.71 |
Q4 2025 | 1 | $0.83 | $0.83 | $0.83 |
Q1 2026 | 0 | $1.14 | $1.14 | $1.14 |
Q2 2026 | 0 | $1.38 | $1.38 | $1.38 |
Q3 2026 | 0 | $1.51 | $1.51 | $1.51 |
Q4 2026 | 0 | $1.47 | $1.47 | $1.47 |
USANA Health Sciences, Inc. last posted its earnings results on Tuesday, April 30th, 2024. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.17. The company had revenue of 227.80 M for the quarter and had revenue of 921.01 M for the year. USANA Health Sciences, Inc. has generated $3 earnings per share over the last year ($3.3 diluted earnings per share) and currently has a price-to-earnings ratio of 13.92. USANA Health Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/07/2024 | Q1 2024 | $0.86 | $226.84 M | $227.80 M | 02/27/2024 | Q4 2023 | $0.88 | $212.42 M | $221.08 M | 11/07/2023 | Q3 2023 | $0.59 | $212.80 M | $213.37 M | 08/08/2023 | Q2 2023 | $0.90 | $238.20 M | 05/09/2023 | Q1 2023 | $0.95 | $248.36 M | 02/28/2023 | Q4 2022 | $0.67 | $227.96 M | 11/08/2022 | Q3 2022 | $0.78 | $233.30 M | 08/09/2022 | Q2 2022 | $1.00 | $264.47 M | 05/11/2022 | Q1 2022 | $1.16 | $272.87 M | 03/01/2022 | Q4 2021 | $1.04 | $267.30 M | 11/10/2021 | Q3 2021 | $1.37 | $274.35 M | 08/11/2021 | Q2 2021 | $1.89 | $336.84 M | 05/11/2021 | Q1 2021 | $1.47 | $307.98 M | 03/02/2021 | Q4 2020 | $1.88 | $310.52 M | 11/03/2020 | Q3 2020 | $1.45 | $298.51 M | 08/04/2020 | Q2 2020 | $1.33 | $258.99 M | 05/05/2020 | Q1 2020 | $1.26 | $266.62 M | 02/25/2020 | Q4 2019 | $1.42 | $271.30 M | 11/05/2019 | Q3 2019 | $1.12 | $260.60 M | 08/06/2019 | Q2 2019 | $0.93 | $254.65 M | $256.02 M |
---|
A. USANA Health Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based off last year's report dates.
A. In the previous quarter, USANA Health Sciences, Inc. (NYSE:USNA) reported $0.86 earnings per share (EPS) to beat the analysts' consensus estimate of $0.69 by $0.17.
A. The conference call for USANA Health Sciences, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for USANA Health Sciences, Inc.'s latest earnings report can be read online.
A. USANA Health Sciences, Inc. (NYSE:USNA) has a recorded annual revenue of $921.01 M.
A. USANA Health Sciences, Inc. (NYSE:USNA) has a recorded net income of $921.01 M. USANA Health Sciences, Inc. has generated $3.31 earnings per share over the last four quarters.
A. USANA Health Sciences, Inc. (NYSE:USNA) has a price-to-earnings ratio of 13.92 and price/earnings-to-growth ratio is -1.73.